Comerica Bank Amphastar Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 12,906 shares of AMPH stock, worth $475,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,906

Previous 13,393 3.64%

Holding current value

$475,457

Previous $535,000 17.01%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.99 - $50.09 $18,014 - $24,393	-487 Reduced 3.64%	12,906 $626,000
Q2 2024 Aug 15, 2024	SELL	$38.65 - $43.48 $84,952 - $95,569	-2,198 Reduced 14.1%	13,393 $535,000
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $50,520 - $74,807	-1,179 Reduced 7.03%	15,591 $684,000
Q4 2023 Feb 14, 2024	BUY	$44.49 - $62.93 $27,583 - $39,016	620 Added 3.84%	16,770 $1.04 Million
Q3 2023 Nov 21, 2023	BUY	$45.51 - $65.0 $734,986 - $1.05 Million	16,150 New	16,150 $742,000
Q4 2022 Jan 26, 2023	SELL	$27.93 - $31.27 $191,041 - $213,886	-6,840 Reduced 24.79%	20,752 $0
Q3 2022 Oct 28, 2022	SELL	$27.56 - $37.75 $73,860 - $101,170	-2,680 Reduced 8.85%	27,592 $852,000
Q2 2022 Aug 02, 2022	BUY	$29.79 - $42.29 $2,681 - $3,806	90 Added 0.3%	30,272 $1.11 Million
Q1 2022 Apr 27, 2022	SELL	$22.96 - $36.45 $99,531 - $158,010	-4,335 Reduced 12.56%	30,182 $1.08 Million
Q4 2021 Feb 18, 2022	BUY	$18.14 - $23.29 $46,982 - $60,321	2,590 Added 8.11%	34,517 $803,000
Q3 2021 Nov 22, 2021	SELL	$17.83 - $21.49 $12,891 - $15,537	-723 Reduced 2.21%	31,927 $606,000
Q2 2021 Aug 26, 2021	SELL	$17.11 - $20.92 $47,548 - $58,136	-2,779 Reduced 7.84%	32,650 $658,000
Q1 2021 Apr 28, 2021	SELL	$17.21 - $20.65 $24,575 - $29,488	-1,428 Reduced 3.87%	35,429 $649,000
Q4 2020 Jan 28, 2021	SELL	$17.76 - $21.24 $195 - $233	-11 Reduced 0.03%	36,857 $741,000
Q3 2020 Oct 30, 2020	BUY	$17.99 - $22.22 $42,006 - $51,883	2,335 Added 6.76%	36,868 $691,000
Q2 2020 Jul 31, 2020	BUY	$14.25 - $22.46 $17,085 - $26,929	1,199 Added 3.6%	34,533 $775,000
Q1 2020 May 01, 2020	BUY	$12.66 - $20.08 $7,671 - $12,168	606 Added 1.85%	33,334 $494,000
Q4 2019 Feb 07, 2020	SELL	$17.07 - $20.64 $238 - $288	-14 Reduced 0.04%	32,728 $631,000
Q3 2019 Oct 31, 2019	SELL	$19.12 - $22.62 $7,896 - $9,342	-413 Reduced 1.25%	32,742 $649,000
Q2 2019 Aug 02, 2019	SELL	$18.92 - $22.96 $29,288 - $35,542	-1,548 Reduced 4.46%	33,155 $0
Q1 2019 May 02, 2019	BUY	$19.46 - $25.28 $14,050 - $18,252	722 Added 2.12%	34,703 $0
Q4 2018 Feb 06, 2019	SELL	$17.72 - $22.51 $2,463 - $3,128	-139 Reduced 0.41%	33,981 $750,000
Q3 2018 Nov 01, 2018	SELL	$15.39 - $19.38 $60,682 - $76,415	-3,943 Reduced 10.36%	34,120 $622,000
Q2 2018 Aug 01, 2018	BUY	$14.63 - $19.6 $15,142 - $20,286	1,035 Added 2.8%	38,063 $625,000
Q1 2018 May 01, 2018	BUY	$17.23 - $20.35 $8,477 - $10,012	492 Added 1.35%	37,028 $721,000
Q4 2017 Feb 02, 2018	SELL	$17.76 - $19.75 $16,943 - $18,841	-954 Reduced 2.54%	36,536 $706,000
Q3 2017 Nov 06, 2017	BUY	$14.73 - $17.99 $552,227 - $674,445	37,490	37,490 $680,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

34.9M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.81B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account